Conditions where inhibition of gastric acid secretion may be beneficial, including aspiration syndromes, dyspepsia, GERD, PUD & Zollinger-Ellison syndrome.
May alter metabolism of some other drugs metabolized by CYP2C19. May prolong elimination of diazepam, phenytoin & warfarin. May reduce absorption of drugs dependent on gastric acid pH eg, ketoconazole & possibly itraconazole.
A02BC01 - omeprazole ; Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
Sign Out
